Sinovac launches world’s 1st phase-III clinical trials in S. Africa for COVID-19 vaccines for groups aged 6 months to 17 years
The world's first phase-III clinical trials for COVID-19 vaccines available for children aged as young as 6 months have been launched in South Africa, Chinese biopharmaceutical firm Sinovac together and…